Potential reasons for this could be: (1) there were no differences in terms of the effects of MMP-11 on mTTP and chemotherapy response in advanced gastric adenocarcinoma; (2) the number of cases studied in the current research was not large enough. Here, MMP11 is linked to gastric adenocarcinoma.